View Single Comment


  1. Phil

    CLF/Rperi – Crap numbers out of China send people out of CLF.   CLF doesn't do any business in China but don't let the facts get in the way of a good panic.   $21.50 was the 50 dma so profit-taking there from $17 not too crazy as SOME PEOPLE don't need to be told to take quick 20% profits off the table.  ;) 

    Why Cliffs Natural Resources Is A Buyat Seeking Alpha

    2 Bullish Analysts See 40% To 100% Upside In Cliffs Natural Resources

    DBA/Randers – They just did a nice, healthy breakout of their 50 dma at $26.  

    DBA was one of our "Five Inflation Fighters Set to Fly" (Part 1 and Part 2) from the 20th and ALSO was one of our "5 Trade Ideas that can make 500% in an Up Market" along with CLF, X, ABX and our 1,844% upside plays that was long AAPL and the Qs (going well so far, thank you very much!).  I don't make posts like this very often, they are essentially when I'm making major top and bottom calls and, historically, they've done very well. 

    If you haven't had a chance to pick up some bullish plays recently, these 10 ideas are good places to start! 



To see many more insightful comments, along with Phil's live intra-day comments, live trading ideas, Phil's market calls, and other members-only features - Subscribe to Phil's Stock World by clicking here.

See our disclaimer here.

 
 
 

ValueWalk

Warren Buffett On Investing, Philanthropy And America's Economy

By VW Staff. Originally published at ValueWalk.


A discussion and Q&A with Warren Buffett. In this discussion Warren answers students question about the Fed, the economy and investing. Warrens discusses philanthropy for the first half of the video with Brain Moynihan.

How Warren Buffett Succeeded: It’s More Than Just Stock Picking

]]> Get The Full Warren Buffett Series in PDF

Get the entire 10-part series on Warren Buffett in PDF. Save it to your desktop, read it on your tablet, or email to your colleagues.

...

more from ValueWalk

Zero Hedge

Dear Congress: Have You Received Money From These Pharma Companies

Courtesy of ZeroHedge. View original post here.

We have been following the latest melodrama involving a "greedy" Mylan, and numerous "humanistic" US politicians, all the way up to the Democratic presidential candidate, exchange blows over the company's dramatic price increases of its EpiPen anti-allergy medication, with a healthy dose of amusement for one simple reason: if Congress wants to crack down on someone, it should crack down on itself.

After all, the only reason Mylan has been able to pass the kinds of price increases that Congress is now blasting it for, is because of US laws and regulations; laws which incidentally, have been determined i...



more from Tyler

Chart School

The "Real" Goods on the July Durable Goods Data

Courtesy of Doug Short's Advisor Perspectives.

Earlier today the Census Bureau posted the Advance Report on the latest Durable Goods New Orders. This series dates from 1992 and is not adjusted for either population growth or inflation.

Let's now review Durable Goods data with two adjustments. In the charts below the gray line shows the goods orders divided by the Census Bureau's monthly population data, giving us durable goods orders per capita. The blue line goes a step further and adjusts for inflation based on the Producer Price Index for All Commodities, chained in today's dollar value. This gives us the "real" durable goods orders per capita and thus a more accurat...



more from Chart School

Phil's Favorites

The Lack Of EpiPen Competitors Is The FDA's Fault

Johnathan Newman makes a good case that the FDA could fix the problem with Mylan controlling the EpiPen market pretty quickly. 

1. Speed up the review of TEVA's generic EpiPen.

2. Approve pre-loaded styringes filled with epinephrine -- the FDA could stop stalling this cheap alternative. 

3. The FDA could reverse course and make it legal for pharmacies to substitute Adrenaclick as a generic alternative to EpiPen. 

(This ...



more from Ilene

Market News

News You Can Use From Phil's Stock World

 

Financial Markets and Economy

PBOC Money-Market Tactic Has Traders Trying to Decode Signal (Bloomberg)

The People’s Bank of China sold 50 billion yuan ($7.5 billion) of 14-day reverse-repurchase agreements on Wednesday, its first offering of anything with a tenor other than seven days since February. 

Anything Goes With Ethical Funds Holding Exxon to Big Tobacco (Bloomberg)

Thinking of putting your money into a fund that describes itself as ethical? You’d better read the fine print if backing Exxon Mobil Corp. and British American Tobacco Plc isn’t your idea...



more from Paul

Kimble Charting Solutions

Gold Mining stocks could be breaking important support

Courtesy of Chris Kimble.

Gold mining stocks have had a great year 2016. From the lows, GDX is up over 100%, remaining inside of a steep rising channel. The rising channel GDX has been in during this historic sharp rally, could be breaking.

CLICK ON CHART TO ENLARGE

GDX has remained inside of the blue rising channel for the majority of 2016. This channel has contained a 100% rally in the past few months.

The rally took GDX up to an unfilled GAP, just below its 38% Fibonacci retrac...



more from Kimble C.S.

Biotech

Epizyme - A Waiting Game

Reminder: Pharmboy is available to chat with Members, comments are found below each post.

Epizyme was founded in 2007, and trying to create drugs to treat patient's cancer by focusing on genetically-linked differences between normal and cancer cells. Cancer areas of focus include leukemia, Non-Hodgkin's lymphoma and breast cancer.  One of the Epizme cofounders, H. Robert Horvitz, won the Nobel Prize in Medicine in 2002 for "discoveries concerning genetic regulation of organ development and programmed cell death."

Before discussing the drug targets of Epizyme, understanding epigenetics is crucial to comprehend the company's goals.  

Genetic components are the DNA sequences that are 'inherited.'  Some of these genes are stronger than others in their expression (e.g., eye color).  Yet, some genes turn on or off due to external factors (environmental), and it is und...



more from Biotech

OpTrader

Swing trading portfolio - week of August 22nd, 2016

Reminder: OpTrader is available to chat with Members, comments are found below each post.

 

This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...



more from OpTrader

Digital Currencies

Man Who Introduced Millions to Bitcoin Says Blockchain Is a Bust

 

Man Who Introduced Millions to Bitcoin Says Blockchain Is a Bust 

By  at Bloomberg

Excerpt:

Stefan Thomas, who introduced millions of people to bitcoin, has had a change of heart.

Blockchain, the ledger software that makes the digital currency possible...



more from Bitcoin

Mapping The Market

Illusion of Choice

From Jean-Luc:

Looks like we are down to about 10 companies for our consumer goods:

http://www.visualcapitalist.com/illusion-of-choice-consumer-brands/

Just like banks, airlines and cable companies! 

The Illusion of Choice in Consumer Brands

Explore the full-size version of the above graphic in all its glory.

If today’s infographic looks familiar, that’s because it originates from a well-circulated report that Oxfam International puts together to show consolidation i...



more from M.T.M.

All About Trends

Mid-Day Update

Reminder: Harlan is available to chat with Members, comments are found below each post.

Click here for the full report.




To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

more from David

Promotions

PSW is more than just stock talk!

 

We know you love coming here for our Stocks & Options education, strategy and trade ideas, and for Phil's daily commentary which you can't live without, but there's more!

PhilStockWorld.com features the most important and most interesting news items from around the web, all day, every day!

News: If you missed it, you can probably find it in our Market News section. We sift through piles of news so you don't have to.   

If you are looking for non-mainstream, provocatively-narrated news and opinion pieces which promise to make you think -- we feature Zero Hedge, ...



more from Promotions

Help One Of Our Own PSW Members

"Hello PSW Members –

This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible.  Feel free to contact me directly at jennifersurovy@yahoo.com with any questions.

Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts.  After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.)  Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.

http://www.youcaring.com/medical-fundraiser/help-get-shadowfax-out-from-the-darkness-of-medical-bills-/126743

Thank you for you time!




FeedTheBull - Top Stock market and Finance Sites



About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>